Nan Tang, M.D., Ph.D.
Founder & Chairman
Nan Tang, M.D., Ph.D., is the founder and chairm of pulmongene, and currently the Principal Investigator of NIBS. Dr. Nan is an internationally renowned expert in pulmonary fibrosis and alveolar regeneration and has more than 20 years’ experience in investigating molecular and cellular drivers that promote alveolar regeneration. She established the first authentic IPF mouse model and identified of novel therapeutic targets of lung diseases. Dr. Tang has co-authored 27 publications and holds 5 patents in the areas of lung diseases and alveolar regeneration, the total impact facter exceeds 390.
Dr. Nan holds a Ph.D. from the University of California, San Diego, USA and subsequently did her research training in the laboratory of Dr. Gail Martin
at the University of California, San Francisco, USA
Rui Zhao, Ph.D.
Vice President, Head of Biology
Dr. Zhaojoined Pulmongene since inception with more than 10 years of experience in lung diseases and novel target discovery. She oversees all early clinical development including target identification & validation, pharmacology, PK/PD, toxicology, biomarker, and clinical pharmacology. Prior to joining Pulmongene, Dr. Zhao served as Principal Investigator III at Genomics Institute of the Novartis Research Foundation (GNF), Novartis, where she lead the respiratory drug portfolio to uncover first-in-class respiratory medicines and oversaw multiple project teams working across different disease areas.
Dr. Zhao received her B.S. from China Agricultural University in 2003 and Ph.D. from National Institute of Biological Sciences, Beijing in 2008. She completed herpost-doc training in the laboratory of Dr. Jayaraj Rajagopal at Massachusetts General Hospital (MGH), Harvard Stem Cell Institute.
Samantha Wood
Scientist
Born on March 14, 1879, in the southern German city of Ulm, Albert Einstein grew up in a middle-class Jewish family in Munich. As a child, Einstein became fascinated by music (he played the violin), mathematics and science. He dropped out of school in 1894 and moved to Switzerland, where he resumed his schooling and later gained admission to the Swiss Federal Polytechnic Institute in Zurich. In 1896, he renounced his German citizenship, and remained officially stateless before becoming a Swiss citizen in 1901.
Toby Maher 医学博士、博士
- 南加州大学凯克医学院临床医学教授、间质性肺病研究主任
- 拥有20余年各类肺纤维化疾病的诊疗与管理经验
- 曾领导伦敦皇家布朗普顿医院间质性肺病诊疗单元
- 参与100余项肺纤维化疾病的临床试验，涵盖1b期到4期阶段；累计为各类干预性临床试验招募患者超1000例